These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30606084)

  • 21. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
    Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
    Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
    Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
    Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
    Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma trimethylamine N-oxide metabolites in the second trimester predict the risk of hypertensive disorders of pregnancy: a nested case-control study.
    Xu H; Feng P; Sun Y; Wu D; Wang D; Wu L; Peng H; Li H
    Hypertens Res; 2024 Mar; 47(3):778-789. PubMed ID: 38177285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
    Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
    J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
    Tang WHW; Li XS; Wu Y; Wang Z; Khaw KT; Wareham NJ; Nieuwdorp M; Boekholdt SM; Hazen SL
    Am Heart J; 2021 Jun; 236():80-86. PubMed ID: 33626384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Concentrations of Trimethylamine-N-oxide Are Directly Associated with Dairy Food Consumption and Low-Grade Inflammation in a German Adult Population.
    Rohrmann S; Linseisen J; Allenspach M; von Eckardstein A; Müller D
    J Nutr; 2016 Feb; 146(2):283-9. PubMed ID: 26674761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-
    Cho CE; Aardema NDJ; Bunnell ML; Larson DP; Aguilar SS; Bergeson JR; Malysheva OV; Caudill MA; Lefevre M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.
    Papandreou C; Bulló M; Hernández-Alonso P; Ruiz-Canela M; Li J; Guasch-Ferré M; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Alonso-Gómez A; Fiol M; Santos-Lozano JM; Serra-Majem L; Liang L; Martínez-González MA; Hu FB; Salas-Salvadó J
    Clin Chem; 2021 Jan; 67(1):288-297. PubMed ID: 33257943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
    Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
    Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimethylamine
    Tang WHW; Lemaitre RN; Jensen PN; Wang M; Wang Z; Li XS; Nemet I; Lee Y; Lai HTM; de Oliveira Otto MC; Fretts AM; Sotoodehnia N; DiDonato JA; Bäckhed F; Psaty BM; Siscovick DS; Budoff MJ; Mozaffarian D; Hazen SL
    Circ Heart Fail; 2024 Aug; 17(8):e011569. PubMed ID: 39119698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association between Plasma Levels of Trimethylamine N-Oxide and the Risk of Coronary Heart Disease in Chinese Patients with or without Type 2 Diabetes Mellitus.
    Dong Z; Liang Z; Guo M; Hu S; Shen Z; Hai X
    Dis Markers; 2018; 2018():1578320. PubMed ID: 30159101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial.
    Zhou T; Heianza Y; Chen Y; Li X; Sun D; DiDonato JA; Pei X; LeBoff MS; Bray GA; Sacks FM; Qi L
    Diabetes Care; 2019 Aug; 42(8):1365-1371. PubMed ID: 31332027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study.
    Talmor-Barkan Y; Yu J; Yacovzada NS; Pravda NS; Ayers C; de Lemos JA; Tang WHW; Hazen SL; Eisen A; Witberg G; Kornowski R; Neeland IJ
    Mayo Clin Proc; 2024 Oct; 99(10):1606-1614. PubMed ID: 38678458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethylamine N-Oxide Metabolites in Early Pregnancy and Risk of Gestational Diabetes: A Nested Case-Control Study.
    Huo X; Li J; Cao YF; Li SN; Shao P; Leng J; Li W; Liu J; Yang K; Ma RCW; Hu G; Fang ZZ; Yang X
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5529-5539. PubMed ID: 31373635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease.
    Bao M; Li H; Li J
    BMC Cardiovasc Disord; 2024 May; 24(1):265. PubMed ID: 38773380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
    Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
    Tang WH; Wang Z; Levison BS; Koeth RA; Britt EB; Fu X; Wu Y; Hazen SL
    N Engl J Med; 2013 Apr; 368(17):1575-84. PubMed ID: 23614584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort.
    Wargny M; Croyal M; Ragot S; Gand E; Jacobi D; Trochu JN; Prieur X; Le May C; Goronflot T; Cariou B; Saulnier PJ; Hadjadj S;
    Cardiovasc Diabetol; 2022 Jun; 21(1):101. PubMed ID: 35681209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.